OXFYY (Oxford Nanopore Technologies) 3-Year Book Growth Rate : -10.50% (As of Dec. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Oxford Nanopore Technologies 3-Year Book Growth Rate?

Oxford Nanopore Technologies's Book Value per Share for the quarter that ended in Dec. 2024 was $3.11.

During the past 12 months, Oxford Nanopore Technologies's average Book Value per Share Growth Rate was -18.00% per year. During the past 3 years, the average Book Value per Share Growth Rate was -10.50% per year. During the past 5 years, the average Book Value per Share Growth Rate was 36.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

During the past 7 years, the highest 3-Year average Book Value per Share Growth Rate of Oxford Nanopore Technologies was 82.60% per year. The lowest was -10.50% per year. And the median was 57.80% per year.

Competitive Comparison of Oxford Nanopore Technologies's 3-Year Book Growth Rate

For the Biotechnology subindustry, Oxford Nanopore Technologies's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Oxford Nanopore Technologies's 3-Year Book Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Oxford Nanopore Technologies's 3-Year Book Growth Rate distribution charts can be found below:

* The bar in red indicates where Oxford Nanopore Technologies's 3-Year Book Growth Rate falls into.

Save Embed

;

Save Embed

;

Oxford Nanopore Technologies 3-Year Book Growth Rate Calculation

This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

Oxford Nanopore Technologies (OTCPK:OXFYY) 3-Year Book Growth Rate Explanation

Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.

Oxford Nanopore Technologies 3-Year Book Growth Rate Related Terms

Thank you for viewing the detailed overview of Oxford Nanopore Technologies's 3-Year Book Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Oxford Nanopore Technologies Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oxford Nanopore Technologies PLC (OTCPK:OXFYY) » Definitions » 3-Year Book Growth Rate

Comparable Companies

Traded in Other Exchanges

ONTTF:USA ONTl:UK ONT:UK 4R0:Germany

Address

Edmund Halley Road, Gosling Building, Oxford Science Park, Oxford, Oxfordshire, GBR, OX4 4DQ

Website

https://www.nanoporetech.com

Oxford Nanopore Technologies PLC makes a novel generation of DNA/RNA sequencing technology that provides rich data and is fast, accessible, and easy to use. The company is predominantly involved in researching, developing, manufacturing, and commercializing a nanopore-based sequencing platform that allows the real-time analysis of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA). This enables its customers to perform scientific/biomedical research in a range of areas, including human genetics, cancer research, outbreak surveillance, environmental analysis, pathogens/antimicrobial resistance, microbiome analysis, and crop science. The company's reportable segments are; Life Science Research Tools which generates key revenue, and COVID Testing.